Cargando…

Synergy between chemotherapy and cancer vaccination

Detalles Bibliográficos
Autores principales:	van der Sluis, Tetje C., van der Burg, Sjoerd H., Melief, Cornelis J.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505152/ https://www.ncbi.nlm.nih.gov/pubmed/26080656

Ejemplares similares

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

Delayed vaccine-induced CD8(+) T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication
por: van der Sluis, Tetje C, et al.
Publicado: (2023)

Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy
por: Sluijter, Marjolein, et al.
Publicado: (2014)

Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function
por: Beyranvand Nejad, Elham, et al.
Publicado: (2020)

Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis
por: Ma, Wenbo, et al.
Publicado: (2016)

Spontaneous tumor rejection by cbl-b–deficient CD8(+) T cells
por: Loeser, Stefanie, et al.
Publicado: (2007)

Molecular Mimicry of Human Cytochrome P450 by Hepatitis C Virus at the Level of Cytotoxic T Cell Recognition
por: Kammer, Andreas R., et al.
Publicado: (1999)

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
por: Cao, Jinfeng, et al.
Publicado: (2016)

CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV
por: Tummers, Bart, et al.
Publicado: (2014)

Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
por: Zom, Gijs G., et al.
Publicado: (2018)

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
por: Melief, Sara M., et al.
Publicado: (2017)

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
por: Çuburu, Nicolas, et al.
Publicado: (2022)

A framework for T cell assays
por: Britten, Cedrik M., et al.
Publicado: (2015)

Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies
por: Vermeij, R., et al.
Publicado: (2011)

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
por: Dijkgraaf, Eveline M., et al.
Publicado: (2015)

Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful
por: van der Burg, Sjoerd H, et al.
Publicado: (2009)

Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes
por: Karim, Rezaul, et al.
Publicado: (2011)

Identification and manipulation of tumor associated macrophages in human cancers
por: Heusinkveld, Moniek, et al.
Publicado: (2011)

Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?
por: Melief, Cornelis J.M.
Publicado: (2022)

Immunotherapy of Human Papilloma Virus Induced Disease
por: van der Burg, Sjoerd H
Publicado: (2012)

Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
por: Beyranvand Nejad, Elham, et al.
Publicado: (2020)

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation
por: Tummers, Bart, et al.
Publicado: (2015)

Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer
por: Talebian Yazdi, Mehrdad, et al.
Publicado: (2016)

Synergy of cancer immunotherapy and radiotherapy
por: Mansfield, Aaron S., et al.
Publicado: (2015)

Future Challenges in Cancer Resistance to Immunotherapy
por: van Elsas, Marit J., et al.
Publicado: (2020)

Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4(+) and CD8(+) T Cell Responses against Mouse Cytomegalovirus Infection
por: Panagioti, Eleni, et al.
Publicado: (2017)

TEIPP peptides: exploration of unTAPped cancer antigens
por: Marijt, Koen A., et al.
Publicado: (2019)

The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools
por: Singh, Satwinder Kaur, et al.
Publicado: (2012)

The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid
por: Smith, Emma Jane, et al.
Publicado: (2012)

TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
por: Zom, Gijs G., et al.
Publicado: (2016)

High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling
por: Tummers, Bart, et al.
Publicado: (2015)

Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
por: Panagioti, Eleni, et al.
Publicado: (2018)

Augmented intelligence: A synergy between man and the machine
por: Bhandari, Mahendra, et al.
Publicado: (2019)

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
por: de Vos van Steenwijk, Peggy J., et al.
Publicado: (2012)

Antibodies against p53 are associated with poor prognosis of colorectal cancer.
por: Houbiers, J. G., et al.
Publicado: (1995)

Monitoring of the Immune Dysfunction in Cancer Patients
por: Santegoets, Saskia J. A. M., et al.
Publicado: (2016)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
por: Verdegaal, Els M. E., et al.
Publicado: (2017)

Synergies and tensions between universal health coverage and global health security: why we need a second ‘Maximizing Positive Synergies’ initiative
por: Ooms, Gorik, et al.
Publicado: (2017)

Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
por: Karim, Rezaul, et al.
Publicado: (2013)

Brief introduction to Synergy-COPD
por: Ratoi, Adina
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tmmbqg4h0gbh7f8rb2ffcjlmls